Zika virus -- Mexico
Abstract
-------
Here we propose a strategy allowing implementing efficient and practicable large-scale seroepidemiological studies for Zika Virus (ZIKV). It combines screening by a commercial NS1 protein-based Zika IgG ELISA, and confirmation by a cytopathic effect-based virus neutralization test (CPE-based VNT). In post-epidemic samples from Martinique Island blood donors (a population with a dengue seroprevalence above 90 percent), this strategy allowed reaching specificity and
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?6293304&promed&0
No comments:
Post a Comment